Ravit Warsha Dor, partner and director at Telus Global Ventures, is one of our top 50 Emerging Leaders in corporate venturing for 2026.
Ravit Warsha Dor is leading investments in Israel for Telus Global Ventures, the CVC arm of Canadian technology company Telus. She has several roles, including sourcing investment opportunities in Israel across all sectors, as well as leading women’s health investments globally and heading AI investments for Telus Digital unit.
Dor is fluent in complex sectors such as health, AI, cybersecurity, agtech and connectivity, and distils them into clear investment theses and deal structures, while actively leveraging and managing a strong and extensive network in Israel and internationally, say her colleagues.
This is the result of a varied career, including working as a research and development manager, doing business development for both large companies and startups, and co-founding a startup. She was also head of innovation for the Israel Ministry of Health and a partner at Kamet Ventures, a VC and venture builder.
“I am excited by the diversity and depth my role provides. I am privileged to work at the forefront of AI, spanning the full stack – from frontier models and core infrastructure to applied systems and production-scale deployment”
Dor has led investments in agtech, AI for food insights and consumer intelligence, as well as a couple of fund investments. “I am excited by the diversity and depth my role provides. I am privileged to work at the forefront of AI, spanning the full stack – from frontier models and core infrastructure to applied systems and production-scale deployment.”
Social impact is embedded in Telus’s values and informs thinking about technology, innovation and long-term value creation. “This deeply rooted, socially aware culture was one of the key factors that attracted me to Telus in the first place,” she says.
Dor is working to promote investments in women’s health technologies on the global stage: “Women’s health is not just fertility, but also key for solving chronic diseases, longevity, cardiovascular, neurological, autoimmune, mental health and many other conditions that are not labelled women’s health at the moment. Closing this gap is not only the right thing to do – it drives better individual outcomes and creates scalable, defensible value across businesses.”
The Emerging Leaders are mid-career corporate venture professionals who are making an outstanding contribution to their teams and the industry.
See the full list of Emerging Leaders here.
